4.7 Review

The role of RNA N6-methyladenosine methyltransferase in cancers

期刊

MOLECULAR THERAPY-NUCLEIC ACIDS
卷 23, 期 -, 页码 887-896

出版社

CELL PRESS
DOI: 10.1016/j.omtn.2020.12.021

关键词

-

资金

  1. National Natural Science Foundation of China [81871871, 81902333]
  2. Key Research and Development Plan (Social Development) of Science and Technology Department of Jiangsu Province [BE2019760]
  3. Medical Innovation Team Foundation of the Jiangsu Provincial Enhancement Health Project [CXTDA2017021]
  4. Postgraduate Research AMP
  5. Practice Innovation Program of Jiangsu Province [KYCX19_1170]
  6. Second Affiliated Hospital of Nanjing Medical University [789ZYRC202090146]

向作者/读者索取更多资源

m(6)A is a modification of eukaryotic RNA that is dynamically regulated during cell metabolism and embryo development, mainly involved in various aspects of RNA metabolism, and closely related to the occurrence and development of cancer. Methyltransferases, as key elements in the dynamic regulation of m(6)A, play a crucial role in these processes.
Modification of eukaryotic RNA by methylation of adenosine residues to generate N-6-methyladenosine (m(6)A) is a highly prevalent process. m(6)A is dynamically regulated during cell metabolism and embryo development, and it is mainly involved in various aspects of RNA metabolism, including RNA splicing, processing, transport from the nucleus, translation, and degradation. Accumulating evidence shows that dynamic changes to m(6)A are closely related to the occurrence and development of cancer and that methyltransferases, as key elements in the dynamic regulation of m(6)A, play a crucial role in these processes. Therefore, in this review, we describe the role of methyltransferases as m(6)A writers in cancer and summarize their potential molecular mechanisms of action.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据